NCT04283994: Project to Improve Communication About Serious Illness–Hospital Study: Comparative Effectiveness Trial (Trial 2)

NCT04283994
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Not Applicable
Drug Category: Other

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: 
Additional Notes: 
Exclusions: Patients younger than 55 years old
https://ClinicalTrials.gov/show/NCT04283994

Comments are closed.

Up ↑